Profil
Dr. Ruurd Stolp is President at Intervet, Inc. He is on the Board of Directors at Malcisbo AG.
Dr. Stolp was previously employed as President by Intervet International BV and President by Intervet.
He received his undergraduate degree from the University of Utrecht.
Postes actifs de Ruurd Stolp
| Sociétés | Poste | Début |
|---|---|---|
Intervet, Inc.
Intervet, Inc. Agricultural Commodities/MillingProcess Industries Develops, manufactures and sales animal health products | President | - |
Anciens postes connus de Ruurd Stolp
| Sociétés | Poste | Fin |
|---|---|---|
Merck Animal Health
Merck Animal Health Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets veterinary medicines & vaccines | President | 01/01/2008 |
Intervet International BV
Intervet International BV Pharmaceuticals: MajorHealth Technology Develops and manufactures veterinary vaccines | President | 02/01/2007 |
Malcisbo AG
Malcisbo AG Pharmaceuticals: MajorHealth Technology Develops novel carbohydrate-based vaccines for human and animal health | Directeur/Membre du Conseil | - |
Formation de Ruurd Stolp
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Intervet International BV
Intervet International BV Pharmaceuticals: MajorHealth Technology Develops and manufactures veterinary vaccines | Health Technology |
Intervet, Inc.
Intervet, Inc. Agricultural Commodities/MillingProcess Industries Develops, manufactures and sales animal health products | Process Industries |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Animal Health
Merck Animal Health Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets veterinary medicines & vaccines | Health Technology |
Malcisbo AG
Malcisbo AG Pharmaceuticals: MajorHealth Technology Develops novel carbohydrate-based vaccines for human and animal health | Health Technology |
















